International Glaucoma Surgical Registry and Elios Vision announce partnership

Article

The open-access tool is the official registry partner of the European Glaucoma Society.

A screen shows a web of file folders, representing data on a digital server. Image credit: ©thodonal – stock.adobe.com

Currently, the IGSR holds data for thousands of procedures across 63 countries. Image credit: ©thodonal – stock.adobe.com

Medical device company Elios Vision, a pioneer in the glaucoma space, announced a partnership with the International Glaucoma Surgical Registry (IGSR). The open-access database is intended to promote information sharing from surgeons worldwide. In a press release, leaders from Elios Vision and the IGSR stated the new collaboration would foster support of, and broader use of, the database.1

“We are delighted to collaborate with and support the objectives of the International Glaucoma Surgical Registry,” said Dr Cameron Hudson, senior vice president OUS of Elios Vision.1 “Capturing long-term, real-world evidence is of high importance especially when adopting and integrating new surgical treatments. We hope the collaboration will encourage other surgeons to utilize the platform for audit and data generation purposes.”

Currently, the IGSR holds data for 7000 procedures across 63 countries. The registry, established over 5 years ago, became the official registry partner of the European Glaucoma Society (EGS) in 2019. Professor Keith Barton, co-founder of the IGSR with Dr Nathan Kerr, also participated in the joint statement.

“We are grateful for the support of Elios Vision in furthering the objectives of the International Glaucoma Surgical Registry and look forward to expanding the capabilities of the Registry through their support,” Barton said.1


Reference

1. Elios Vision Announces Collaboration with the International Glaucoma Surgical Registry. News release. Elios Vision, Inc., July 4, 2023. Accessed July 5, 2023.
Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.